Key risk factors include: History of pancreatitis caution is advised in patients with previous pancreatitis Pre-existing gastrointestinal disease particularly severe gastroparesis or severe GORD Gallbladder disease rapid weight loss itself increases gallstone risk Concurrent medications particularly NSAIDs, anticoagulants, or other drugs affecting gastric mucosa Helicobacter pylori infection if present, may increase ulcer risk independently Diabetic gastroparesis in patients with diabetes, pre-existing delayed gastric emptying may be exacerbated It should be noted that animal studies have shown an increased incidence of thyroid C-cell tumours with semaglutide, though the clinical relevance to humans is unknown
Platelet-rich plasma injections PRP therapy involves drawing a small amount of your blood, concentrating the platelets through centrifugation, and injecting the platelet-rich concentrate directly into the scalp at the level of the hair follicles
Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A, Sikiric S, Bekic D, Soldo D, Grizelj B, Novosel L, Beketic Oreskovic L, Oreskovic I, Stupnisek M, Boban Blagaic A, Dobric I
We dont want to just treat you with medication, says Dr
Research on GLP-1 receptors in the brain has suggested potential roles in learning, memory, and mood regulation (Durante et al., 2013
Comparative Efficacy: Weight Loss Outcomes (SURMOUNT vs STEP) There are no published head-to-head clinical trials comparing semaglutide and tirzepatide directly